Adverum Biotechnologies, Inc.
ADVMDelisted Dec 9, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501756
Adverum Biotechnologies, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 10, 2025; 50 institutions reported holding it in 13F filings for Q3 2025, worth $63.8M in total; no superinvestor held it.
Holders of 5% or more of ADVM
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Adverum Biotechnologies, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| TCG Crossover GP II, LLC | 13G/A | 8.90%1.87M shares | – | Feb 15, 20242 filings | May 15, 2025 | SEC |
| Rush Ryan Bradford | 13G | 5.10%1.05M shares | New | Dec 17, 20241 filing | Dec 17, 2024 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
68 Schedule 13D and 13G filings on Adverum Biotechnologies, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Dec 9, 20256:05 PM ET | BML Investment Partners, L.P.and 1 other | 13D/A | 0.00%0 shares | −9.70 ppfrom 9.70%Below 5% | Dec 9, 2025 | SEC |
| Dec 9, 20255:31 PM ET | Frazier Life Sciences Public Fund, L.P.and 13 others | 13G/A | 0.00%0 shares | −19.40 ppfrom 19.40%Below 5% | Dec 9, 2025 | SEC |
| Dec 5, 20256:18 PM ET | BML Investment Partners, L.P.and 1 other | 13D/A | 9.70%2.15M shares | −5.90 ppfrom 15.60% | Dec 4, 2025 | SEC |
| Nov 28, 20253:25 PM ET | Frazier Life Sciences Public Fund, L.P.and 13 others | 13G/A | 19.40%4.29M shares | +14.00 ppfrom 5.40% | Nov 25, 2025 | SEC |
| Nov 10, 202512:32 PM ET | BML Investment Partners, L.P.and 1 other | 13D/A | 15.60%3.25M shares | 0.00 ppfrom 15.60% | Nov 10, 2025 | SEC |
| Aug 14, 20251:04 PM ET | Frazier Life Sciences Public Fund, L.P.and 19 others | 13G/A | 5.40%1.13M shares | – | Aug 12, 2025 | SEC |
| Aug 5, 202511:51 AM ET | Franklin Resources Incand 2 others | 13G/A | 0.00%0 shares | −8.50 ppfrom 8.50%Below 5% | Jun 30, 2025 | SEC |
| Jul 16, 20257:02 PM ET | BlackRock, Inc. | 13G/A | 2.00%414.5K shares | –Below 5% | Jun 30, 2025 | SEC |
| May 20, 20258:27 AM ET | BML Investment Partners, L.P.and 1 other | 13D | 15.60%3.25M shares | +1.80 ppfrom 13.80% | May 19, 2025 | SEC |
| May 15, 20254:34 PM ET | TCG Crossover GP II, LLCand 2 others | 13G/A | 8.90%1.87M shares | – | Mar 31, 2025 | SEC |
| May 6, 20259:15 AM ET | BML Investment Partners, L.P.and 1 other | 13G/A | 13.80%2.88M shares | +2.40 ppfrom 11.40% | Mar 31, 2025 | SEC |
| Feb 14, 20256:10 PM ET | Venrock Healthcare Capital Partners III, L.P.and 6 others | 13G/A | 0.00%0 shares | –Below 5% | Dec 31, 2024 | SEC |
| Feb 13, 20253:25 PM ET | BML Investment Partners, L.P.and 1 other | 13G/A | 11.40%2.37M shares | – | Dec 31, 2024 | SEC |
| Dec 17, 20245:11 PM ET | Rush Ryan Bradford | 13G | 5.10%1.05M shares | New | Dec 17, 2024 | SEC |
| Nov 14, 2024 | Commodore Capital LP | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Vivo Opportunity Fund Holdings, L.P. | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Logos Global Management LP | 13G/AOld format | – | – | – | SEC |
| Nov 12, 2024 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Nov 8, 2024 | BlackRock, Inc. | 13GOld format | – | – | – | SEC |
| Nov 6, 2024 | Morgan Stanley | 13G/AOld format | – | – | – | SEC |
| Oct 31, 202412:41 PM ET | Franklin Resources Incand 3 others | 13G | 8.50%1.76M shares | New | Sep 30, 2024 | SEC |
| Oct 30, 2024 | Stern Augustus | 13GOld format | – | New | – | SEC |
| Oct 23, 2024 | Principia Wealth Advisory, LLC | 13GOld format | – | New | – | SEC |
| Oct 22, 2024 | BlackRock, Inc. | 13GOld format | – | New | – | SEC |
| Jul 22, 2024 | BML Investment Partners, L.P. | 13G/AOld format | – | – | – | SEC |
| May 14, 2024 | Versant Ventures IV, LLC | 13D/AOld format | – | – | – | SEC |
| Apr 29, 2024 | BML Investment Partners, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 22, 2024 | Logos Global Management LP | 13GOld format | – | New | – | SEC |
| Feb 15, 2024 | TCG Crossover GP II, LLC | 13GOld format | – | New | – | SEC |
| Feb 14, 2024 | Commodore Capital LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Vivo Opportunity Fund Holdings, L.P. | 13GOld format | – | New | – | SEC |
| Feb 14, 2024 | Venrock Healthcare Capital Partners III, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Bank of America Corp | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2024 | Morgan Stanley | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2024 | Frazier Life Sciences Public Fund, L.P. | 13GOld format | – | New | – | SEC |
| Feb 9, 2024 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 7, 2024 | BML Investment Partners, L.P. | 13G/AOld format | – | – | – | SEC |
| Jul 24, 2023 | Venrock Healthcare Capital Partners III, L.P. | 13GOld format | – | New | – | SEC |
| Apr 20, 2023 | Commodore Capital LP | 13GOld format | – | New | – | SEC |
| Feb 14, 2023 | Soleus Capital Master Fund, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | RTW Investments, LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Avoro Capital Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Bank of America Corp | 13GOld format | – | New | – | SEC |
| Feb 9, 2023 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2023 | BML Investment Partners, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2023 | Morgan Stanley | 13GOld format | – | New | – | SEC |
| Dec 30, 2022 | Sonic Fund II, L.P. | 13D/AOld format | – | – | – | SEC |
| Sep 2, 2022 | Soleus Capital Master Fund, L.P. | 13GOld format | – | New | – | SEC |
| Jul 8, 20224:57 PM ET | BlackRock Inc. | 13GOld format | – | – | – | SEC |
| May 10, 2022 | BML Investment Partners, L.P. | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Adverum Biotechnologies, Inc. shares.
No Form 144 notices for Adverum Biotechnologies, Inc. are on file.